The introduction of nicotinamide being a nicotine alternative in e-cigarette and smokeless items signifies a significant regulatory problem for that FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is understood to act as a sedative at substantial dosages6. The claims produced by Nicotine River, ECBlend, along with other vendors